PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | Varlitinib | C22H19ClN6O2S

Varlitinib

  • Molecular FormulaC22H19ClN6O2S
  • Average mass466.943 Da
  • Monoisotopic mass466.097870 Da
  • ChemSpider ID25027380
  • defined stereocentres - 1 of 1 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

4,6-Quinazolinediamine, N4-[3-chloro-4-(2-thiazolylmethoxy)phenyl]-N6-[(4R)-4,5-dihydro-4-methyl-2-oxazolyl]- [ACD/Index Name]
845272-21-1 [RN]
846Y8197W1
9187
N4-[3-Chlor-4-(1,3-thiazol-2-ylmethoxy)phenyl]-N6-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]-4,6-chinazolindiamin [German] [ACD/IUPAC Name]
N4-[3-Chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-N6-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]-4,6-quinazolinediamine [ACD/IUPAC Name]
N4-[3-Chloro-4-(1,3-thiazol-2-ylméthoxy)phényl]-N6-[(4R)-4-méthyl-4,5-dihydro-1,3-oxazol-2-yl]-4,6-quinazolinediamine [French] [ACD/IUPAC Name]
varlitinib [Spanish] [INN]
varlitinib [French] [INN]
Varlitinib [INN] [USAN]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

ARRY-334543 [DBID]
ARRY334543 [DBID]
ARRY-543 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      EGFR MedChem Express HY-10530
      JAK/STAT Signaling MedChem Express HY-10530
      JAK/STAT Signaling; MedChem Express HY-10530
      Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM, respectively. MedChem Express HY-10530
      Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM, respectively. ;IC50 value: 2 nM (ErbB2), 7 nM (ErbB1);Target: ErbB;In vitro: Varlitinib is an orally bioavailable inhibitor of the epidermal growth factor receptor family with potential antineoplastic activity. Varlitinib selectively and reversibly binds to both EGFR (ErbB-1) and Her-2/neu (ErbB-2) and prevents their phosphorylation and activation, which may result in inhibition of the associated signal transduction pathways, inhibition of cellular proliferation and cell death. EGFR and Her-2 play important roles in cell proliferation and differentiation and are upregulated in various human tumor cell types. Due to the dual inhibition of both EGFR and Her-2, this agent may be therapeutically more effective than agents that inhibit EGFR or Her-2 alone.;In vivo: When dosed orally, ARRY334543 prevents growth of human tumor xenografts that overexpress ErbB-1 (A431) or ErbB-2 (MDA-MB- MedChem Express HY-10530

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.5±0.1 g/cm3
Boiling Point: 637.1±65.0 °C at 760 mmHg
Vapour Pressure: 0.0±1.9 mmHg at 25°C
Enthalpy of Vaporization: 94.1±3.0 kJ/mol
Flash Point: 339.1±34.3 °C
Index of Refraction: 1.742
Molar Refractivity: 124.5±0.5 cm3
#H bond acceptors: 8
#H bond donors: 2
#Freely Rotating Bonds: 7
#Rule of 5 Violations: 0
ACD/LogP: 3.51
ACD/LogD (pH 5.5): 2.84
ACD/BCF (pH 5.5): 46.26
ACD/KOC (pH 5.5): 266.18
ACD/LogD (pH 7.4): 3.88
ACD/BCF (pH 7.4): 510.52
ACD/KOC (pH 7.4): 2937.48
Polar Surface Area: 122 Å2
Polarizability: 49.4±0.5 10-24cm3
Surface Tension: 60.1±7.0 dyne/cm
Molar Volume: 308.1±7.0 cm3

Click to predict properties on the Chemicalize site






Advertisement